(2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide

This compound is a synthetic small molecule belonging to the class of quinazolinamines, which are heterocyclic aromatic compounds containing a quinazoline moiety substituted by one or more amine groups. The specific structure features a 3-bromophenylamino group at the 4-position and a dimethylaminobut-2-enamide side chain at the 6-position of the quinazoline core. It is classified as an experimental agent and has not been approved for clinical use. Its primary known molecular target is proto-oncogene tyrosine-protein kinase Src, suggesting potential utility as a kinase inhibitor in oncology research[2]. No clinical indications or approved uses are currently associated with this compound.